AEPCX
Price
$62.33
Change
-$0.26 (-0.42%)
Updated
Oct 17 closing price
Net Assets
137.72B
FNGAX
Price
$18.16
Change
+$0.02 (+0.11%)
Updated
Oct 17 closing price
Net Assets
809.5M
Interact to see
Advertisement

AEPCX vs FNGAX

Header iconAEPCX vs FNGAX Comparison
Open Charts AEPCX vs FNGAXBanner chart's image
American Funds EUPAC C
Price$62.33
Change-$0.26 (-0.42%)
VolumeN/A
Net Assets137.72B
Franklin Intl Growth A
Price$18.16
Change+$0.02 (+0.11%)
VolumeN/A
Net Assets809.5M
AEPCX vs FNGAX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. FNGAX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and FNGAX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 138B vs. FNGAX (810M). FNGAX pays higher dividends than AEPCX: FNGAX (1.65) vs AEPCX (0.16). AEPCX was incepted earlier than FNGAX: AEPCX (25 years) vs FNGAX (17 years). AEPCX (1.57) is less costly to investors than FNGAX (1.20). AEPCX is a more actively managed with annual turnover of: 35.00 vs. FNGAX (17.56). AEPCX has a lower initial minimum investment than FNGAX: AEPCX (250) vs FNGAX (1000). AEPCX annual gain was more profitable for investors over the last year : 10.02 vs. FNGAX (6.65). AEPCX return over 5 years is better than : 9.92 vs. FNGAX (-5.83).
AEPCXFNGAXAEPCX / FNGAX
Total Expense Ratio1.571.12140%
Annual Report Gross Expense Ratio1.571.20131%
Fund Existence25 years17 years-
Gain YTD20.63112.537165%
Front LoadN/A6%-
Min. Initial Investment250100025%
Min. Initial Investment IRAN/AN/A-
Net Assets138B810M17,037%
Annual Yield % from dividends0.161.6510%
Returns for 1 year10.026.65151%
Returns for 3 years45.8541.28111%
Returns for 5 years9.92-5.83-170%
Returns for 10 years36.7677.2448%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CIGI157.623.03
+1.96%
Colliers International Group
NTRSO20.000.04
+0.20%
Northern Trust Corp
BRNS1.33-0.02
-1.33%
Barinthus Biotherapeutics plc
JANX26.76-0.44
-1.62%
Janux Therapeutics
NVEC71.97-1.42
-1.93%
NVE Corp